{
    "code": 0,
    "data": [
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements)\r\nRegulations 2015 the Audio recording of Conference Call held on Monday November 17 2025 is available on\r\nthe website of the Company the link of the same is stated herein-below:\r\nhttps://www.naturalcapsules.com/pdf/Audio%20Recording%20of%20the%20Investors%20Conference%20Call%\r\n20dated%20November%2017%202025.mp3\r\n\r\nKindly take the aforesaid information on record in compliance of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "news_id": "cbc8d15d-fa53-4b92-83a6-46b2fce63aee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc0c6651-e999-4447-96e1-c2239a5441ef.pdf",
            "news_date": "2025-11-17 18:43:11",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed investor presentation",
            "news_id": "ca6fd419-e04d-42c1-9d7a-7614e527de05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01b9f0b0-5c6c-4c17-b304-23ceb20143f3.pdf",
            "news_date": "2025-11-14 08:19:01",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Un-audited Financials for the Quarter and half year ended 30th September 2025",
            "news_id": "c9823a34-6ef3-4c19-98bd-89e46f1413d2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e23c25-d620-4cc2-8ff7-8c269f431e7b.pdf",
            "news_date": "2025-11-13 17:04:15",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed copy of investor presentation in connection with Un-audited Standalone and Consolidated Financial results for the quarter ended 30th June 2025",
            "news_id": "2885a00a-5a01-4599-a80a-e883ede64945",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbd4e547-ce46-43d1-bbff-2f33392afaea.pdf",
            "news_date": "2025-08-05 06:57:58",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Please find enclosed Unaudited Consolidated and Standalone Financial Results for the Quarter ended 30th June 2025",
            "news_id": "edffaa78-a863-4dfb-9e88-459181131cd6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3477a1b-0430-4543-bc0b-f41618a31cef.pdf",
            "news_date": "2025-08-04 19:05:34",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 and Part A of schedule III  of SEBI(LODR)2015 we enclosed herewith a copy of Transcript of conference call held on Wednesday4th June 2025.",
            "news_id": "44141bb9-e2a9-4add-af1d-0e6b1156c09c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=320c2a35-373d-4f6a-bb4b-b572941ec728.pdf",
            "news_date": "2025-06-11 12:06:14",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Audio recording of Conference Call held on Wednesday 4th June 2025 is available on the website of the company the link of the same is stated herein-below:\r\n\r\nhttps://www.naturalcapsules.com/pdf/Concall-NATURAL%20CAPSULES%20LTD-04062025.mp3 \r\n\r\nKindly take the aforesaid information on record in compliance of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "news_id": "7cb5db4a-4fd7-4e19-b7f2-45e9a2c7db54",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0072baef-644a-45a2-b1b9-a05180bf629d.pdf",
            "news_date": "2025-06-04 18:44:37",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the copy of investor presentation in connection with Audited Standalone & Consolidated Financial Results for the quarter and year ended 31st March 2025",
            "news_id": "ddbbaf1f-8564-455c-a60a-649366a67fd4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f320790-c0d8-4d75-b67e-926630f0c593.pdf",
            "news_date": "2025-05-31 14:21:25",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended On 31St March2025",
            "news_body": "This is to inform that the board of directors at their meeting held on Thursday May 29th 2025 have approved the Audited standalone & consolidated financial results for the quarter and year ended 31st March 2025",
            "news_id": "3d460d68-3e74-43c8-9ca6-5e6b216a218d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fbea33f-bd39-4ab6-a776-8866f3b8aeb0.pdf",
            "news_date": "2025-05-29 20:40:36",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith copy of investors presentation in connection with unaudited standalone and consolidated financials for the quarter ended 31.12.2024.",
            "news_id": "787dc0ae-d86e-4cf8-90b5-5162463ec066",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4318d39d-549f-480c-a052-9da769d2ef19.pdf",
            "news_date": "2025-02-12 22:16:53",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financials Results For The Quarter Ended 31.12.2024",
            "news_body": "This is to inform that Board of Directors at their meeting held on 12.02.2025 have approved unaudited financial results for the quarter ended 31.12.2024",
            "news_id": "0f989a82-db84-46dc-aa63-c27a9a47f1d6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9552f2a-2e31-4ee4-a531-6d4f93c53b7a.pdf",
            "news_date": "2025-02-12 17:45:39",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 (LODR), We wish to inform that the Company participated in the investors conference call on Monday, 18.11.2024, enclosed herewith please find the transcript of earnings conference call on unaudited financial results for the quarter and half year ended 30.09.2024.",
            "news_id": "258908d4-f5ef-42ff-a1a3-b4c03a9eca9d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42e75bb1-1d1e-4426-a3cd-376587266462.pdf",
            "news_date": "2024-11-20 16:36:05",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30, Please find enclosed herewith copy of Investor Presentation in connection with unaudited financial results for the quarter and half year ended 30.09.2024.",
            "news_id": "57ec350a-af11-4398-9920-687f2bf2d207",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cdb2ef6-4acf-4c33-b380-a818fff0edb1.pdf",
            "news_date": "2024-11-13 16:39:34",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year 30.09.2024",
            "news_body": "This is t0 inform that Board on their meeting held on 12.11.2024, have approved the unaudited consolidated and standalone financial results for the period ended 30.09.2024.",
            "news_id": "15f63c01-5c33-413d-ae1e-bc00604bf591",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc1d8dbf-33d7-4cfb-b6be-90e3bc5d3495.pdf",
            "news_date": "2024-11-12 18:04:11",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Consolidated And Standalone Financial Results For The Quarter Ended 30.06.2024",
            "news_body": "This is to inform that Board of Directors have approved the unaudited consolidated and standalone financial results for the quarter ended 30.06.2024 at their meeting held on 13.08.2024.",
            "news_id": "718206a8-0d7d-4825-b897-4ca08df94c21",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e41d7833-8970-4474-8ebb-629db0198086.pdf",
            "news_date": "2024-08-13 18:05:51",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of SEBI, LODR, we wish to inform you that Company participated in the investors conference call on Monday, 27.05.2024, enclosed herewith please find transcript of earning conference call on Audited Financial Results for the quarter and financial year ended 31.03.2024. No unpublished price sensitive information was shared/discussed in the meeting.",
            "news_id": "4b89975f-2f28-4e30-97ff-590940485a1b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd2964b5-1669-4efc-82cd-880f86482618.pdf",
            "news_date": "2024-05-29 16:44:53",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish toinform you that the Company participated in the Investors Conference Call today i.e. Monday, 27th May, 2024 onaudited financial results for the quarter and financial year ended 31st March 2024.No unpublished price sensitive information was shared/discussed in the meeting.Audio of the conference call has been uploaded at the Company's website: https://www.naturalcapsules.com/pdf/Audio%20recording%20for%20investors%20conference%20call%20-%2027.05.2024.mp3",
            "news_id": "5cd89e2e-0914-4bd7-ba3c-6b842db50474",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dce3629-29dc-4937-bc54-bda2463fca9a.pdf",
            "news_date": "2024-05-27 19:24:18",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI, LODR, Please find enclosed herewith investor presentation in connection with Audited Financials for the period ended 31.03.2024.",
            "news_id": "683e6271-9bbb-4be3-9fde-4fb125d26404",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e2f2b63-0634-4e82-8852-b2851c90cf97.pdf",
            "news_date": "2024-05-23 20:07:34",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Audited Consolidated And Standalone Financial Results For The Quarter And Financial Year Ended 31.03.2024",
            "news_body": "This is to inform you that Board at their meeting held on 21.05.2024 have approved audited standalone and consolidated financial results for the period ended 31.03.2024.",
            "news_id": "5396013b-a3c3-45ec-80ea-820457b5e095",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84a749be-ee4c-4c81-907d-cc40ec24e51e.pdf",
            "news_date": "2024-05-21 19:22:14",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of securities and exchange board of India (Listing obligations and Disclosure Requirements )Regulations,2015 ,Please Find enclosed herewith copy of Presentation made to the analysts and investors in connection with unaudited Standalone & Consolidated Financial Results for Quarter ended 31st December 2023",
            "news_id": "d7f85a96-76d3-4573-b66f-8d063dd303b4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1ca1150-e2f7-41ca-96c9-1bf1720b177a.pdf",
            "news_date": "2024-02-10 09:30:57",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Unaudited & Consolidated Financial Results For The Period Ended 31.12.2023",
            "news_body": "This is to inform that Board of Directors at their meeting held today, have considered and approved unaudited and consolidated financial results for the period ended 31.12.2023. The Board Meeting commenced at 03.30 PM and concluded at 05.30 PM",
            "news_id": "92f86cb8-57a6-46ff-a2ae-d89bd03d203d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=475ddecb-c856-4dd5-91d2-29e4dbb00ec8.pdf",
            "news_date": "2024-02-09 17:53:31",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30, Please find enclosed herewith Investor Presentation in connection with unaudited standalone and consolidated financials for the quarter and half year ended 30.09.2023",
            "news_id": "ba007fdf-fbdf-4915-a257-b54a11b2024a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22259b66-468f-46fc-830b-9a3ff982adfe.pdf",
            "news_date": "2023-11-10 09:07:35",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Unaudited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2023",
            "news_body": "This is to inform you that, the Board of Directors at their meeting held today i.e. Thursday, November 9, 2023 have considered and approved unaudited standalone and consolidated financial results for the quarter and half year ended 30.09.2023.The Board Meeting commenced at 03.30 PM and concluded at 04.45 PM.",
            "news_id": "9e92f512-6bf7-4caf-a2d8-fa3c01bc1911",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18e0a3c6-c182-4701-89e6-547fcb65317c.pdf",
            "news_date": "2023-11-09 17:02:32",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Please find enclosed herewith the copy of presentation made to analysts and investors in connection with unaudited standalone and consolidated financial results for the quarter ended 30.06.2023",
            "news_id": "71d436dc-22a7-4093-a07b-b2bb5692bd2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7868cf6d-7815-4c7b-bcd5-a6c391494321.pdf",
            "news_date": "2023-08-10 09:42:15",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "This is to inform that Board at their meeting held today i.e. August 9, 2023 have approved unaudited consolidated and standalone financial results for the quarter ended 30.06.2023.<BR>",
            "news_id": "b3b46240-fdb6-4e35-bd39-5e3c1b5cdd7e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de7b08dc-1b16-4bd6-9234-99bec5e660f2.pdf",
            "news_date": "2023-08-09 19:08:26",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "A. This is to inform that the Board of the Directors at their meeting held today, i.e. Wednesday, August 9, 2023, have:<BR>  <BR> 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023.<BR>  <BR> 2. Approved sending Reminder cum forfeiture notice to the holders of such partly paid-up equity shares who have failed to pay the First Call, Second & Final call or both the Call Monies on the following terms:<BR> 1 Call payment period Begins on August 17, 2023<BR> Ends on August 31, 2023<BR> 2 Period available to pay 15 days<BR> 3 Rate of interest for delayed payment 8% p.a. <BR> 4 Acceptable modes of payment Demand Draft<BR> 5 Detailed instructions Will form part of the Final Reminder cum Forfeiture Notice and shall be uploaded on the Company''s website viz., www.naturalcapsules.com in due course.<BR> <BR> B. The Board Meeting commenced at 04.00 PM and concluded at 06.50 PM.<BR> <BR>",
            "news_id": "46b4dd7b-dc11-47ac-b2ef-7c770e1bece5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca1e95bd-4ddd-4567-907b-e69b7b44cd8c.pdf",
            "news_date": "2023-08-09 19:02:13",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of presentation made to analysts and investors in connection with Audited Standalone & Consolidated Financial Results for quarter & financial year ended 31st March, 2023.",
            "news_id": "b1d8c42e-8e3e-4d85-b3fb-e9d7c553e0ae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eeb55a7c-0115-473a-9e71-820300558e7c.pdf",
            "news_date": "2023-05-28 15:45:41",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Audited Standalone & Consolidated Financial Results For The Period Ended 31.03.2023",
            "news_body": "Further to our intimation dated 26.05.2023, due to inadvertence, there were some typing errors on consolidated Financial Results and dividend amount per equity share. We hereby submit the revised outcome of Board Meeting.<BR> <BR> A. This is to inform that the Board of the Directors at their meeting held on Friday, May 26, 2023, have:<BR> <BR> 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and Financial year ended March 31, 2023.<BR> <BR> 2. Recommended dividend @ 10% i.e.  Re. 1/-(one) per equity share of Rs. 10/- (ten) each subject to the approval of the shareholders at the ensuing 30th Annual General Meeting (AGM) of the Company;<BR> <BR> 3. Record date for the entitlement of Dividend, and date & timings for ensuing Annual General Meeting of the Company shall be intimated in due course of time.<BR> <BR>",
            "news_id": "2dd0b28e-bb2c-42be-a362-c1af34025d51",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eced586f-0269-4d3c-9f7f-552f2c3ee96e.pdf",
            "news_date": "2023-05-27 17:01:28",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Audited Standalone And Consolidated Financial Results For The Period Ended 31.03.2023",
            "news_body": "A. This is to inform that the Board of the Directors at their meeting held today, i.e. Friday, May 26, 2023, have:<BR> <BR> 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and Financial year ended March 31, 2023.<BR> <BR> 2. Recommended dividend @ 10% i.e.  Rs. 0.10/- per equity share of Rs. 10/- each subject to the approval of the shareholders at the ensuing 30th Annual General Meeting (AGM) of the Company;<BR> <BR> 3. Record date for the entitlement of Dividend, and date & timings for ensuing Annual General Meeting of the Company shall be intimated in due course of time.<BR> <BR>",
            "news_id": "7f73a401-0f27-485e-a1df-7e80a940cab4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3afdee8a-2f40-4f01-9f32-bef2da7db64d.pdf",
            "news_date": "2023-05-26 19:15:41",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of presentation made to analysts and investors in connection with Un-Audited Standalone & Consolidated Financial Results for quarter ended 31st December, 2022.",
            "news_id": "283b9fda-3529-43c3-989f-6667467619e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1bd7382-8575-41d3-a2c8-771895554f7f.pdf",
            "news_date": "2023-02-13 19:26:18",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone & Consolidated Financial Results For The Period Ended 31.12.2022",
            "news_body": "A. This is to inform that the Board of the Directors at their meeting held today, i.e. Monday, February 13, 2023, have:<BR> <BR> Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2022.<BR> <BR> B. The Board Meeting commenced at 03.00 PM and concluded at 05.45 PM.<BR> <BR> <BR>",
            "news_id": "b14a904c-2d4e-44ed-a47a-12e82f4da2c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=052fba5c-1d56-4805-a9cd-4de49c075e75.pdf",
            "news_date": "2023-02-13 18:01:18",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Period Ended 30.09.2022",
            "news_body": "Pursuant to the provisions of Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the relevant disclosure on Related Party Transactions of the Company in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended September 30, 2022.",
            "news_id": "87273029-d3f3-4262-b909-c5c3609b2fb3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3ba1b5c-2365-4eca-969f-6e60c5cdb988.pdf",
            "news_date": "2022-11-09 16:14:32",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of presentation made to analysts and investors in connection with Un-Audited Standalone & Consolidated Financial Results for quarter & half year ended 30th September, 2022.",
            "news_id": "85bc4d4a-d808-4e8e-8bd4-a80788161734",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=139175c0-8b87-4a58-ae61-92c0ceea4d1e.pdf",
            "news_date": "2022-10-28 20:52:41",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Consolidated & Standalone Financial Results For The Period Ended 30.09.2022",
            "news_body": "Outcome of Board Meeting held on October 28, 2022<BR> <BR> A. This is to inform that the Board of the Directors at their meeting held today, i.e. Friday, October 28, 2022, have:<BR> <BR> 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2022.<BR> <BR> 2. Approval on making balance 50% right issue second & final call money.  <BR>",
            "news_id": "b002670f-9581-4ccc-91c3-7c9c07e0eb7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59dbdd95-c1d6-41ed-86e7-5c3b21a2c286.pdf",
            "news_date": "2022-10-28 19:19:22",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting<BR> <BR>",
            "news_body": "A. This is to inform that the Board of the Directors at their meeting held today, i.e. Friday, October 28, 2022, have:<BR> 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2022.<BR> 2. Approval on making balance 50% right issue second & final call money. <BR> <BR> <BR>",
            "news_id": "f863a072-1dd9-43eb-bace-6a682a3b972f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c97289d-25e1-4ba1-a191-337be1360719.pdf",
            "news_date": "2022-10-28 19:13:48",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of presentation made to analysts and investors in connection with Un-Audited Standalone & Consolidated Financial Results for quarter ended 30th June, 2022.You are requested to take the information on record and oblige.",
            "news_id": "754328e3-d08c-45fd-8322-c289958ec7c4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=363c0efa-ba73-47d2-931a-4942e62671b0.pdf",
            "news_date": "2022-08-12 14:05:33",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30.06.2022",
            "news_body": "Outcome of Board Meeting held on August 10, 2022<BR> <BR> This is to inform that the Board of the Directors at their meeting held today, i.e. Wednesday, August 10, 2022, have:<BR> <BR> 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2022.<BR> <BR> 2. Considered resignation of Mr. Anjan Kumar Roy from the services of the Company as Independent Director.<BR> <BR> 3. Considered and approved Appointment of Mr. S. G. Belapure as additional director (Independent) of the Company with immediate effect, to hold office up to the date of ensuing Annual General Meeting ('AGM') of the Company, subject to approval of the members at the ensuing AGM of the Company, Mr. S. G. Belapure shall hold office as an Independent director for a period of 5 (five years) with immediate effect.  <BR> <BR> 4. To fix date of AGM as  20th,September 2022.<BR> <BR> 5. Outcome of Nomination, Remuneration & Compensation Committee<BR> <BR>",
            "news_id": "010ffd05-9bb2-44c4-8006-aab9f8decb44",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b423a8e2-7577-40ac-804e-127eb22a82a3.pdf",
            "news_date": "2022-08-10 19:05:44",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Period Ended 31.03.2022",
            "news_body": "In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the enclosed disclosure of Related Party Transactions in the format specified in the relevant accounting standards for the half year ended 31.03.2022.Kindly take the above information on your record.",
            "news_id": "f643622f-1ce3-4269-9c49-85ae86fdcb48",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ea80ac0-1b82-4c3c-8bba-00dd59dabe41.pdf",
            "news_date": "2022-05-17 16:01:46",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of presentation made to analysts and investors in connection with Audited Standalone & Consolidated Financial Results for quarter ended 31st March, 2022.You are requested to take the information on record and oblige.",
            "news_id": "51310b1f-90ce-47c6-a4a0-a37bde594ff6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=354e73ed-a100-490f-84a2-12b17c5c90eb.pdf",
            "news_date": "2022-05-09 22:51:40",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Period Ended 31.03.2022",
            "news_body": "A. This is to inform that the Board of the Directors at their meeting held today, i.e. Monday, May 9, 2022, have:<BR> <BR> 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2022.<BR> <BR> 2. Recommended dividend of Re.1/- per equity share of Rs. 10/- each subject to the approval of the members.<BR> <BR> 3. Approval on making first call money of 25%. The record date for the same is 25.05.2022.<BR> <BR> 4. Considered and approved Appointment of Mr. R K Prasad as new Chief Financial officer & Key Managerial Personnel of the Company with immediate effect.<BR> <BR> 5. Considered retirement of Mr. Prasanna Junnarkar from the services of the Company as Chief Financial Officer on attaining superannuation.  <BR>",
            "news_id": "075a438a-0f8d-4257-a62a-06dd7d1f3a42",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a200168c-2b9a-4bc8-b5b3-8f5d60e2adc0.pdf",
            "news_date": "2022-05-09 19:51:29",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of presentation made to analysts and investors in connection with Un-Audited Standalone & Consolidated Financial Results for quarter ended 31st December, 2021You are requested to take the information on record and oblige.",
            "news_id": "844a0235-954f-42c7-b102-831df0f70486",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8caef1f-3206-406b-9074-1e9f2a6d5ccb.pdf",
            "news_date": "2022-02-08 18:15:52",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Period Ended 31.12.2021",
            "news_body": "This is to inform that the Board of the Directors at their meeting held today, i.e. Tuesday, February 08, 2022, inter alia has transacted the following:<BR> <BR> 1. Adoption of Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2021.<BR> <BR> Further in compliance with regulation 33 of SEBI (Listing Obligations and Disclosures Requirements), Regulations 2015, we submit herewith, the Unaudited Standalone and Consolidated financial results along with Limited Review Report for the quarter ended December 31, 2021.<BR> <BR> The Board Meeting commenced at 04.00 PM and concluded at 06.00 PM.<BR> <BR> Kindly take the aforesaid information on record in compliance of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. <BR>",
            "news_id": "01715b61-7a20-496f-942d-b972e949c846",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=181f3375-aed6-472c-a2c4-f5a924b8a81d.pdf",
            "news_date": "2022-02-08 18:12:13",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 08, 2022",
            "news_body": "This is to inform that the Board of the Directors at their meeting held today, i.e. Tuesday, February 08, 2022, inter alia has transacted the following:<BR> <BR> 1. Adoption of Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2021.<BR> <BR> Further in compliance with regulation 33 of SEBI (Listing Obligations and Disclosures Requirements), Regulations 2015, we submit herewith, the Unaudited Standalone and Consolidated financial results along with Limited Review Report for the quarter ended December 31, 2021.<BR> <BR> The Board Meeting commenced at 04.00 PM and concluded at 06.00 PM.<BR> <BR> Kindly take the aforesaid information on record in compliance of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. <BR>",
            "news_id": "229b5b44-f223-4e18-8b69-a3466bb31d50",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1353c21f-0232-4930-81da-4b9fb7860912.pdf",
            "news_date": "2022-02-08 18:07:36",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 30.09.2021",
            "news_body": "In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the enclosed disclosure of Related Party Transactions in the format specified in the relevant accounting standards for the half year ended 30.09.2021.<BR> Kindly take the above information on your record.<BR>",
            "news_id": "e6de32cb-98d9-4182-b7c3-1d757e19bc91",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3429b3ad-3786-4041-bcb2-6ee29d1ff3fd.pdf",
            "news_date": "2021-11-22 12:29:21",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of presentation made to analysts and investors in connection with Un-Audited Standalone & Consolidated Financial Results for quarter and half year ended 30th September, 2021<BR> <BR> You are requested to take the information on record and oblige.<BR> <BR>",
            "news_id": "0970acec-6cd4-4f0e-ab47-335e8e056064",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69e4ac9c-220f-4d62-b93b-e71ffdbfb173.pdf",
            "news_date": "2021-11-01 17:10:30",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Consolidated & Standalone Financial Results For The Period Ended 30.09.2021",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at their meeting held today i.e. on October 30, 2021 at its registered office, inter alia, considered and approved Unaudited Consolidated & Standalone Financial Results for the period ended 30.09.2021 and other business as per the attachment.",
            "news_id": "92f2962c-bb29-46f1-8f8a-ca3b22cf89a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b01461c5-c257-42dd-8ead-74a0e9162bfe.pdf",
            "news_date": "2021-10-30 18:08:41",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at their meeting held today i.e. on October 30, 2021 at its registered office, inter alia, considered and approved the business as per the attachment.",
            "news_id": "0876c917-90b6-447e-90c8-c55fd42aa84f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f981c41-a370-4ef5-8f82-727fa9d6009e.pdf",
            "news_date": "2021-10-30 18:00:55",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "Results - Financial Results for the quarter ended June 30, 2021",
            "news_id": "8eeb783c-db98-4cc2-8dd4-79013c78b9d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22d859cc-4be2-4677-a864-f5a497299a5a.pdf",
            "news_date": "2021-08-07 19:44:05",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2021",
            "news_body": "Outcome of Board Meeting held on August 07, 2021",
            "news_id": "b86871cd-9522-48b6-aecc-e79f02a328a2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d976d31-957a-4f74-b55f-8ec8d51a9331.pdf",
            "news_date": "2021-08-07 19:39:59",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2021",
            "news_body": "In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the enclosed disclosure of Related Party Transactions in the format specified-in the relevant accounting standards for the half year ended March 31, 2021.",
            "news_id": "90a989da-7ca3-4496-b8ef-2619980ba7d3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e97ddc1d-bae4-403c-8745-666e52800c07.pdf",
            "news_date": "2021-06-14 20:37:40",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATCAPSUQ",
            "disp": "Natural Capsules",
            "bse_code": 524654,
            "isin": "INE936B01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For March 31, 2021 (Consolidated & Standalone)",
            "news_body": "Results - Financial Results for March 31, 2021 (Consolidated & Standalone)",
            "news_id": "45c5ef7c-6519-4bf0-bc94-06f813c584b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef55e1ad-fcee-461f-9e9c-b5a67264a014.pdf",
            "news_date": "2021-05-31 20:31:52",
            "seo": "natural-capsules-ltd",
            "ltp": 162.59,
            "ch": -1.4000000000000057,
            "pch": -0.8537105921092784,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 29583,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}